Microarray technology has demonstrated the power of high-throughput approaches to unravel key biological processes [ 20, 21].
Microarray technology has demonstrated differential expression in OA cartilage of a variety of IL-1-induced, NFβB-dependent genes.
In recent years, microarray technology has demonstrated the power of the high-throughput study of gene expression in unravelling key processes in plant biology [ 1- 3].
In the last years, microarray technology has demonstrated the power of the high-throughput study of gene expression in the unravelling of key processes of plant biology [ 2- 4].
Microarray technology has demonstrated the power of high-throughput approaches to unravel key biological processes and identify useful candidate genes and promoters for genetic engineering.
Resequencing Pathogen Microarray technology has demonstrated potential for differential diagnosis of several respiratory pathogens simultaneously, but a high confidence design method to select probes for genetically diverse viruses is lacking.
Another use of microarray technology was demonstrated by L Assersohn (Royal Marsden Hospital, London, UK), who used it to examine fine-needle aspirates taken from tumours before, during and after presurgical tamoxifen treatment.
Son et al. (2012), using microarray technology, also demonstrated gradients of gene expression in the adult and developing mouse cochlea, a subset of which (approximately 5% of those genes assayed) exhibited clear spatial and temporal variations in expression along the cochlear duct.
To use microdissection and DNA microarray technology to demonstrate differences in gene expression between epithelial and stromal areas in the proliferative human endometrium.
In this study, we combined a random amplification strategy with high-density resequencing microarray technology to demonstrate simultaneous detection and sequence-based typing of 25 geographically distributed human influenza virus strains collected in 2004 and 2005.
